Abstract
Achmea (Amsterdam, the Netherlands) is one of the largest healthcare insurers in the Netherlands, serving more than 3.3 million customers. To retain that position, it is important that we look for innovative methods of guaranteeing customers good quality care and managing cost increases in the future. Achmea hopes that disease management programmes will enable it to introduce new methods of optimizing the healthcare process, while also serving the needs of customers and motivating them as regards prevention. We see opportunities in disease management programmes supported by telemedicine technology. We are therefore currently involved in conducting the Hartmotief study to determine whether telemonitoring can enhance our customers’ quality of life, and whether telemonitoring can be cost-effective in managing patients with chronic heart failure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
